| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |